Objectives-Multiple types of mediastinal masses, especially masses in the anterior mediastinum, may be encountered in routine echocardiographic examinations for symptomatic or asymptomatic patients. The aim of this study was to evaluate the diagnostic value of transthoracic echocardiography combined with contrastenhanced ultrasonography in determining the location, composition, and vascularization of mediastinal masses.
C linically, mediastinal masses represent a wide diversity of disease states. Usual symptoms in patients with mediastinal masses are chest pain, cough, fevers, chills, and dyspnea, 1 although most patients are asymptomatic and masses are incidentally discovered by imaging. Radiologic methods, including computed tomography (CT) 2 and magnetic resonance imaging (MRI), 3, 4 have always been the most used imaging methods for diagnosing mediastinal masses. Conventional transthoracic echocardiography (TTE) might be the first imaging modality to identify mediastinal masses, especially in patients presenting with chest pain and dyspnea. Several investigations have suggested that some extracardiac lesions, such as mediastinal masses, inferior vena cava filling defects, and descending aortic dilatation, can be found on noninvasive cardiac imaging. In addition, these new findings would lead to new diagnoses and altered management in these patients. 5 In fact, some mediastinal masses, especially large ones or those located in the anterior mediastinum, can be easily detected through the intercostal space, which constitutes an acoustic window during TTE. 6 Until now, few systematic studies have been conducted to explore the application of TTE in diagnosing mediastinal masses. In this study, TTE was used to image mediastinal space-occupying lesions, providing information about the location, echogenicity, and relationships with adjacent structures of the masses. In addition, contrast-enhanced ultrasonography (CEUS) was further performed to provide more details on vascularization to narrow the differential diagnosis.
Materials and Methods

Study Participants
Our institution is a tertiary referral teaching hospital. From November 2015 to July 2017, 48 consecutive patients who had an initial diagnosis of mediastinal masses by echocardiography were recruited for this study. The diagnoses of all of the patients were further confirmed by CT, surgery, or pathologic analysis. This study was approved by the Tongji Hospital Ethics Committee, and informed consent was obtained from all patients before the study. All procedures performed were in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Echocardiographic Imaging
Conventional TTE and CEUS were performed with a Vivid E9 digital ultrasonography (US) system (GE Healthcare, Horten, Norway) equipped with an M5S array transducer (with a transmission frequency of 1.7-3.4 MHz).
Transthoracic Echocardiography
Two-dimensional images were captured with a frame rate of at least 70 frames per second, and 3 beats were recorded for analysis. Images of the parasternal long-axis, parasternal short-axis, apical 4-chamber, apical 2-chamber, apical long-axis, and suprasternal long-axis views of the aortic arch were acquired, as well as other nonstandard planes if necessary.
Contrast-Enhanced US
Twenty-five patients with a diagnosis of parenchymal or mixed lesions by TTE underwent CEUS. For this procedure, 1.5 mL of the sulfur hexafluoride microbubble contrast agent SonoVue (Bracco SA, Geneva, Switzerland) was intravenously infused through the antecubital vein. Meanwhile, mediastinal masses were imaged with the preset real-time myocardial contrast perfusion imaging modality. The mechanical index was preset to 0.08, and the frame rate was preset to 22 frames per second to reduce microbubble destruction. Microbubbles within mediastinal masses and the myocardium were destroyed by a high-mechanical index (1.0) US impulse transmitting at least 20 frames when the mediastinal masses were opacified with SonoVue microbubbles. After this impulse, gradual contrast replenishment of the mass was visualized. All images were digitally stored on the hard disk of the machine. Patients were observed at rest for 30 minutes to ensure safety without any complications.
Imaging Analysis
The location, size, morphologic structure, echogenicity, and relationships with adjacent structures of the mediastinal mass were determined by TTE. An analysis of CT results was completed by radiologists.
In this study, the mediastinum was divided into 4 compartments, namely, the superior, anterior, middle, and posterior portions of the mediastinum, according to Gray's classic classification of the multiple echocardiographic views. 7 On the parasternal long-and short-axis views, the area in front of the anterior wall of the right ventricle, aorta, and pulmonary artery was identified as the anterior mediastinum. From the apical views, the area behind the atriums and pulmonary veins was identified as the posterior mediastinum. The area between the anterior mediastinum and posterior mediastinum was defined as the middle mediastinum. The masses detected on the suprasternal plane were identified as superior mediastinal lesions.
The echogenicity of the mediastinal masses was determined by a comparison with the echogenicity of the heart structures. Anechoic was defined as an echo in the heart cavity. Hypoechoic was defined as an echo in the myocardium. Hyperechoic was defined as an echo in the epicardium. A mixed echo mainly referred to the combination of hypoechoic and anechoic or hyperechoic and anechoic.
For the parenchymal (hyperechoic and hypoechoic) and mixed lesions diagnosed by TTE, CEUS was performed to determine the mass vascularization. After the high-mechanical index impulse, contrast enhancement of the mediastinal masses was assessed visually by comparison with the enhancement of the adjacent myocardium. This assessment was performed by 2 independent sonologists who were blinded to all clinical information, including the final diagnoses of the patients. The semiquantitative classification was based on the following rules: grade 1, no enhancement within the mediastinal mass; grade 2, incomplete or partial enhancement within the mediastinal mass, lower than that within the adjacent myocardium; and grade 3, complete enhancement within the mediastinal mass, higher than that within the adjacent myocardium.
Statistical Analysis SPSS version 17.0 software (IBM Corporation, Armonk, NY) was used for statistical analysis. Continuous variables were expressed as mean 6 1 SD. Continuous variables were compared by a paired-samples t test. P < .05 was statistically significant.
Results
Population Characteristics
The study included 21 male and 27 female patients with a mean age of 43 6 17 years (age range, 17-76 years). This movement was verified. Forty-eight mediastinal masses detected first by TTE were included in this study. The locations, pathologic types, and clinical manifestations of the population are summarized in Table  T1 1. Final operations and pathologic examinations revealed that there were 27 malignant and 21 benign tumors.
Echocardiographic Findings of Mediastinal Masses Location and Size
Based on multiple TTE views, 48 mediastinal masses were divided into the 4 compartments in this study ( Table 1) . The locations of all of the mediastinal masses determined by TTE were consistent with those from CT or surgical findings.
In the 48 masses, the longest diameter measured by echocardiography was significantly lower than that measured by CT (67.63 6 27.22 versus 76.38 6 34.23 mm; P 5 .013). In addition, there was also a difference in the shortest diameter between echocardiography and CT (51.52 6 22.86 versus 57.94 6 31.73 mm; P 5 .038).
Morphologic Structure and Echogenicity
In this study, 8 mediastinal masses appeared as homogeneously anechoic with thin walls on US. These masses were determined to be cystic lesions and further diagnosed as pericardial and thymic cysts on the basis of pathologic findings.
A total of 34 mediastinal masses appeared as hypoechoic or hyperechoic parenchymal lesions on US. Inhomogeneity and an irregular shape were found in 16 solid masses ( Figure  F1  1 ). The rest of the 18 solid masses were well defined and circular or oval ( Figure  F2  2 ). Final operations and pathologic examinations revealed that there were 26 malignant and 8 benign tumors.
In the 6 mixed masses that presented as cysts combined with solid lesions or floating echoes on US, 5 lesions were finally diagnosed as benign tumors, including mature teratomas, a schwannoma, and a pericardial cyst. Only 1 mixed lesion was determined to be thymic carcinoma complicated with necrosis. 
Spatial Extent of Masses and Relationship With the Heart and Great Vessels
In this study, a total of 27 mediastinal masses were determined to be malignant tumors by validated diagnoses. Among these malignant tumors, 23 lesions had aggressive features shown on US, including 8 masses accompanied by hydropericardium, 6 masses compressing the heart ( Figure  F3 3), and 12 masses wrapping around the great vessels or superior vena cava. There were 4 cases showing no obvious compression or encroachment on US, which were confirmed as invasive tumors by CT or surgery. In the 21 benign masses, there were 5 large masses that compressed the heart or the great vessels to different degrees, including 3 cases of teratoma, 1 case of a pericardial cyst, and 1 case of schwannoma.
Blood Perfusion
In 25 patients who underwent CEUS, there were 15 malignant and 10 benign lesions, which were confirmed by operations and pathologic examinations. As observed in Table  T2 2, in 15 malignant mediastinal masses, 12 masses showed complete enhancement (grade 3) on CEUS (Figure 1) , and 3 masses showed incomplete enhancement (grade 2). In 10 benign lesions, 2 masses showed complete enhancement (grade 3); 6 masses showed incomplete enhancement (grade 2; Figure 2) ; and 2 masses showed no enhancement (grade 1) on CEUS.
Discussion
For a long time, CT has been the preferred imaging method for diagnosing mediastinal masses. Magnetic resonance imaging is not routinely used to investigate mediastinal masses, but it can identify cysts, vascular structures, and nerves with precision so that masses that are highly vascular are readily detected. [2] [3] [4] In comparison, US is an underused imaging modality for diagnosing mediastinal masses. In fact, US could be superior to CT and MRI in some special situations, such as pregnant women, children, and patients in 
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intensive care units, since it is a convenient, noninvasive, and radiation-free imaging method. In this study, we sought to explore the diagnostic value of TTE by systematically analyzing the US features of mediastinal masses. Moreover, CEUS was first performed to identify the vascularization of the masses.
Division of the mediastinum into specific compartments is used to determine the anatomic locations of newly detected mediastinal masses, which contribute to an elaborate differential diagnosis and planning of further surgical procedures. 7 Generally, the most frequent masses encountered in the anterior mediastinum are thymoma, lymphoma, and teratoma. In the posterior mediastinum, a neurogenic tumor is the main pathologic type. It was not difficult for TTE to accurately localize the mediastinal masses, since the anatomic locations determined from multiple echocardiographic views were all consistent with CT or surgical findings in this study. Despite this ability, the measurements of the mediastinal masses on TTE were significantly underestimated compared with those obtained by CT. Mediastinal accessibility of TTE is often limited by bony parts of the thorax and pulmonary air. Therefore, although it is relatively easy for TTE to detect mediastinal masses, full displays of huge masses (>100 mm) or masses located in the posterior mediastinum are still quite difficult to detect by US. Transesophageal echocardiography could be an alternative imaging method for some masses in the posterior mediastinum. Because of the higher resolution and the closer contact with the mass, transesophageal echocardiography would produce clear, complete images without disturbances from bony parts and pulmonary air.
The morphologic structure and echogenicity are important for identifying the tissue components and narrow down the differential diagnosis of mediastinal masses by pathologic type. With high sensitivity, US is superior to other imaging examinations in detecting cystic lesions. Cystic lesions in the mediastinum can be of various origins, including bronchogenic cysts, pericardial cysts, thymic cysts, cystic teratoma, and lymphangioma. Simple cystic lesions are anechoic internally and surrounded by thin cyst walls with posterior acoustic 
enhancement, most of which are benign. 8 However, cystic lesions accompanied by floating echoes or solid components often indicate some complications such as hemorrhage and infection or other mixed histologic types. Solid mediastinal masses usually present as hypoechoic or hyperechoic masses on US. Some of these US features are helpful in distinguishing benign from malignant lesions. Generally, benign solid mediastinal masses often appear well defined and regularly contoured. In contrast, malignant tumors, such as lymphoma and invasive thymoma, present as distinct inhomogeneous hypoechoic or hyperechoic masses with irregular shapes. The large solid mediastinal mass in our study was found to integrate into a larger nodule with necrotic areas, which was finally determined to be a malignant tumor by pathologic analysis. Due to various types of tissues and origins in mediastinal masses, these echo characteristics for distinguishing benign from malignant lesions are not absolutely applicable in every case.
Echocardiography can accurately detect the relationship between mediastinal masses and the heart and great vessels, and it is also able to show real-time motion or slight spatial displacement of masses with reference to contiguous structures, along with cardiac pulsations or respiratory fluctuation. Localizing symptoms are secondary to tumor invasion, which affects clinical stages, surgical methods, and the prognosis. In general, mediastinal masses can be conveniently classified into the following types. 9 Anterior mediastinal masses usually compress right heart chambers, and posterior mediastinal masses compress the left atrium or left ventricle. Some masses compress large veins, such as superior mediastinal ones compressing the superior vena cava or juxtahilar ones compressing the pulmonary veins entering the left atrium. There are also some other masses that produce combinations of the 3 varieties above or 1 of them, with large pericardial effusion and tamponade. 1 Mediastinal masses affecting the heart and adjacent great vessels reveal their invasiveness. 10 In this study, 20 cases that compressed or encroached on the heart and vessels were accurately assessed to narrow the differential diagnosis, whereas the remaining 2 cases were confirmed by surgery or other imaging examinations. In addition, superior to CT, echocardiography is able to disclose esophageal cancer invading the inner structure of the heart.
Contrast-enhanced US is a new technique that makes use of microbubble-based contrast agents to improve the echogenicity of blood and thus improves the visualization of cardiac cavities, large vessels, and tissue vascularity. Compared with contrast agents used in CT, US contrast agents are free of ionizing radiation and can be used in patients with renal dysfunction or iodine allergies, for whom enhanced CT and MRI may be contraindicative. Currently, an increasing number of studies use CEUS to investigate tumor angiogenesis, which has been validated in differentiating malignant masses from benign ones in the liver, 11 kidney, 12 breast, 13 and thyroid.
14 Recently, Tang et al 15 concluded that cardiac thrombi and benign and malignant tumors had different degrees of enhancement on CEUS, and assessment of the degree of enhancement of cardiac masses had high diagnostic accuracy in the differentiation of a thrombus from a tumor or a benign tumor from a malignant tumor. To our knowledge, CEUS was first used in this 
study to determine the vascularization of mediastinal masses. Although our study used CEUS in limited cases, there is no doubt that it performs outstandingly in clinical diagnosis. Some cysts containing nonserous fluid may be mistaken for solid lesions on conventional US. In this situation, cystic lesions can be accurately distinguished from solid masses, presenting as well-defined masses without enhancement on CEUS. On pathologic specimens, malignant mediastinal tumors usually show abundant neovascularization and blood supply compared with benign neoplasms. Among these 25 mediastinal masses, most of the malignant masses were completely enhanced, but most of the benign masses showed incomplete enhancement or no enhancement on CEUS. At this point, TTE combined with CEUS might become a new means to differentiate benign from malignant masses by providing information about different degrees of enhancement in mediastinal masses. Different from enhanced CT scanning, CEUS could be used to observe the whole process of enhancement in real time. The 6 lymphomas in our study had typical features of fast, inhomogeneous contrast enhancement on CEUS. Although our study indicated that the degrees of enhancement on CEUS were in agreement with CT enhancement in most of the mediastinal masses, CEUS showed 2 enhanced tumors that had negative findings on CT and were finally confirmed to be lymphoma and chronic granuloma by pathologic examinations separately. It is important to note that misdiagnosis may occur when some benign mediastinal tumors are also highly vascular. 16, 17 In this study, 2 schwannomas appeared as richly vascularized and completely enhanced on CEUS.
There were some limitations in this study. First, given the small number of patients and the variability of the mediastinal tumor type, we could not make a definite conclusion on the sensitivity and specificity of CEUS in discriminating malignant tumors from benign ones. Second, mediastinal accessibility of TTE is often limited by bony parts of the thorax and pulmonary air. Therefore, some masses, especially those located in the posterior mediastinum, are difficult to detect with high quality. In this situation, transesophageal echocardiography would provide more details. Taquiso et al 18 reported a mass in the left atrium and pulmonary vein, which was thought to indicate spreading from a primary lung malignancy. The diagnostic value of transesophageal echocardiography in mediastinal masses should be included to make the conclusions more convincing in future studies. Third, although our study demonstrated that CEUS can be used to determine the grade of vascularization in mediastinal masses, contrast enhancement may be underestimated for the masses in the posterior mediastinum because of the acoustic attenuation in the distant field.
In conclusion, for mediastinal masses adjacent to the heart, TTE is a convenient and noninvasive imaging technique, which can be easily performed to provide effective diagnostic information about the location, morphologic and US features, and relationship with the heart and the great vessels. Combined with CEUS, the degree of vascularization in mediastinal masses could be further determined, which could contribute to providing more details for narrowing the differential diagnosis.
